发明名称 |
RBM3 IN BLADDER CANCER |
摘要 |
The present disclosure relates, in one of its aspects, to a method for determining whether a mammalian subject having a bladder cancer belongs to a first or a second group, wherein the prognosis of subjects of the first group is better than the prognosis of subjects of the second group. The method comprises the steps of: a) evaluating an amount of RBM3 in at least part of a sample earlier obtained from the subject and determining a sample value corresponding to the evaluated amount; b) comparing said sample value with a predetermined reference value; and if said sample value is higher than said reference value, c1) concluding that the subject belongs to the first group; and if said sample value is lower than or equal to said reference value, c2) concluding that the subject belongs to the second group. |
申请公布号 |
WO2012156330(A1) |
申请公布日期 |
2012.11.22 |
申请号 |
WO2012EP58826 |
申请日期 |
2012.05.11 |
申请人 |
ATLAS ANTIBODIES AB;EBERHARD, JAKOB;JIRSTROEM, KARIN |
发明人 |
EBERHARD, JAKOB;JIRSTROEM, KARIN |
分类号 |
C07K14/47;C07K16/00;G01N33/574 |
主分类号 |
C07K14/47 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|